Efficacy and Safety of Alirocumab in Children and Adolescents With Homozygous Familial Hypercholesterolemia: Phase 3, Multinational Open-Label Study.
Éric BruckertSonia CaprioAlbert WiegmanMin-Ji CharngCézar A Zárate-MoralesMarie T Baccara-DinetGaren ManvelianAnne OurliacMichel ScemamaStephen R DanielsPublished in: Arteriosclerosis, thrombosis, and vascular biology (2022)
gov; NCT03510715.